Cataplexy

Revision as of 17:25, 11 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cataplexy
ICD-10 G47.4
ICD-9 347
DiseasesDB 16311
MeSH D002385

WikiDoc Resources for Cataplexy

Articles

Most recent articles on Cataplexy

Most cited articles on Cataplexy

Review articles on Cataplexy

Articles on Cataplexy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cataplexy

Images of Cataplexy

Photos of Cataplexy

Podcasts & MP3s on Cataplexy

Videos on Cataplexy

Evidence Based Medicine

Cochrane Collaboration on Cataplexy

Bandolier on Cataplexy

TRIP on Cataplexy

Clinical Trials

Ongoing Trials on Cataplexy at Clinical Trials.gov

Trial results on Cataplexy

Clinical Trials on Cataplexy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cataplexy

NICE Guidance on Cataplexy

NHS PRODIGY Guidance

FDA on Cataplexy

CDC on Cataplexy

Books

Books on Cataplexy

News

Cataplexy in the news

Be alerted to news on Cataplexy

News trends on Cataplexy

Commentary

Blogs on Cataplexy

Definitions

Definitions of Cataplexy

Patient Resources / Community

Patient resources on Cataplexy

Discussion groups on Cataplexy

Patient Handouts on Cataplexy

Directions to Hospitals Treating Cataplexy

Risk calculators and risk factors for Cataplexy

Healthcare Provider Resources

Symptoms of Cataplexy

Causes & Risk Factors for Cataplexy

Diagnostic studies for Cataplexy

Treatment of Cataplexy

Continuing Medical Education (CME)

CME Programs on Cataplexy

International

Cataplexy en Espanol

Cataplexy en Francais

Business

Cataplexy in the Marketplace

Patents on Cataplexy

Experimental / Informatics

List of terms related to Cataplexy

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Cataplexy is a medical condition which often affects people who have narcolepsy, a disorder whose principal signs are EDS (Excessive Daytime Sleepiness), sleep attacks, sleep paralysis, hypnopompic hallucinations[1] and disturbed night-time sleep. Cataplexy is sometimes confused with epilepsy, where a series of flashes or other stimuli cause superficially similar seizures.

The term cataplexy originates from the Greek kata, meaning down, and plexis, meaning a stroke or seizure.

Presentation

Cataplexy manifests itself as muscular weakness which may range from a barely perceptible slackening of the facial muscles to the dropping of the jaw or head, weakness at the knees, or a total collapse. Usually the speech is slurred, vision is impaired (double vision, inability to focus), but hearing and awareness remain normal. These attacks are triggered by strong emotions such as exhilaration, anger, fear, surprise, orgasm, awe, embarrassment and laughter.

Cataplexy may be partial or complete, affecting a range of muscle groups, from those controlling facial features to (less commonly) those controlling the entire body. [2]

  • Arm weakness
  • Sagging jaw
  • Drooping head
  • Slumping of the shoulders
  • Slurred speech
  • Generalized weakness
  • Knee buckling

When cataplexy happens often, or cataplexy attacks make patients fall or drop things, it can have serious affects on normal activities. It can cause accidents and be embarrassing when it happens at work or with friends. For example, a narcoleptic may not pick up a baby because they are afraid they may drop them. [3]

Treatment

Despite its relation to narcolepsy, in most cases, cataplexy must be treated differently and separate medication must be taken. For many years, cataplexy has been treated with tricyclic antidepressants such as imipramine, clomipramine or protriptyline. However these can have unpleasant side-effects and so have been generally replaced by newer drugs such as Effexor, a more recent antidepressant. Xyrem, the brand-name of the compound (sodium)gamma-Hydroxybutyrate GHB, has been shown to treat not only cataplexic attacks, but in narcoleptics, it has also been shown to significantly reduce daytime sleepiness.[4] Monoamine oxidase inhibitors may be used to manage both cataplexy and the REM sleep-onset symptoms of sleep paralysis and hypnagogic hallucinations.[1]

A person's efforts to stave off cataplectic attacks by avoiding these emotions may greatly diminish their lives, and they may become severely restricted emotionally if diagnosis and treatment is not begun as soon as possible. [5]

Diagnosis

Cataplexy in severe cases can cause vital signs to be hard to detect without a continuous auditory pulse oximeter (a well-known heart monitor). As an anecdotal example, one Allison Burchell, a sufferer of severe Cataplexy, has been sent to the morgue three times.[6]

References

  1. 1.0 1.1 "Narcolepsy". Childhood Sleep Disorders. Armenian Medical Network. 2006. Retrieved 2007-09-19. Text " Thomas F. Anders, M.D. " ignored (help)
  2. "Cataplexy". Sleep Disorders - Cataplexy. 2007. Retrieved 2007-09-19.
  3. "Cataplexy Introduction for Patients". Jazz Pharmaceuticals, Inc. 2007. Retrieved 2007-09-19.
  4. Black J, Houghton WC (2006). "Sodium oxybate improves excessive daytime sleepiness in narcolepsy". Sleep. 29 (7): 939–46. PMID 16895262.
  5. "Narcolepsy and Cataplexy". NODSS Narcolepsy and Overwhelming Daytime Sleep Society of Australia. Retrieved 2007-09-19.
  6. "The woman who died three times". The Argus. 2000-10-18. Retrieved 2006-12-20.

External links

Template:Diseases of the nervous system Template:SIB

bg:Катаплексия de:Kataplexie nl:Kataplexie no:Katapleksi simple:Cataplexy sv:Kataplexi


Template:WH Template:WS